Read previous post:
Catalyst Health CEO David Blair will now be working with SXC Health's Mark Thierer. Last Wednesday, the two companies merged in a $4.4-billion deal.
Versant analyst Tom Liston Raises Target on SXC Health to $103

Last Wednesday, SXC Health (TSX:SXC) announced it would merge with rival Catalyst Health in a cash and stock transaction valued...

Close